AB Science completes EUR 14.2 million private placement

• AB Science priced a EUR 14.2 million private placement via unregistered share sales to a small group of investors.
• Existing long-term investor subscribed EUR 12 million; CEO Stéphane Ledermann also invested.
• Issued 23,278,692 new shares at EUR 0.61 each, a 24.87% discount to the prior 3-day VWAP of EUR 0.81.
• Each share carries a warrant; full exercise would add 36,590,166 shares, raising about EUR 36 million at EUR 1 per share.
• Cash position seen around EUR 23 million; proceeds earmarked for R&D, including AB8939 in AML, masitinib in ALS.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB Science SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608100155OMX_____CNEWS_EN_GNW1001256772_en) on August 10, 2026, and is solely responsible for the information contained therein.